← Back to Dashboard

Biktarvy

Integrase strand transfer inhibitor + 2x NRTI

Constituent drugs (3)

Bictegravir

Could not render structureView on PubChem
3D not available

Emtricitabine

Could not render structureView on PubChem
3D not available

Tenofovir Alafenamide

Could not render structureView on PubChem
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral integrase + RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (kegg.jp) Approval ref (pmda.go.jp) PMDA approved 2019/3/26fixed-dose combination of Bictegravir, Emtricitabine, Tenofovir alafenamide.